Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

about

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

Item

http://www.wikidata.org/entity/Q47712185

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@en

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@nl

type

Item

label

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@en

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@nl

prefLabel

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@en

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@nl

P1476

Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.

@en

P2093

Jin Wang

http://www.w3.org/2001/XMLSchema#string

Kai Wang

http://www.w3.org/2001/XMLSchema#string

Mingpei Pang

http://www.w3.org/2001/XMLSchema#string

Qian Liu

http://www.w3.org/2001/XMLSchema#string

Qingle Chen

http://www.w3.org/2001/XMLSchema#string

Sihai Tan

http://www.w3.org/2001/XMLSchema#string

Wenjie Wu

http://www.w3.org/2001/XMLSchema#string

Zhangyong Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics

Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Photodynamic therapy and anti-tumour immunity.

Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.

Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor

Integrin targeted delivery of chemotherapeutics

Prodrugs for improving tumor targetability and efficiency.

Photodynamic therapy of cancer: an update

P304

310-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.22362

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29344278

http://www.w3.org/2001/XMLSchema#string

P932

5771339

http://www.w3.org/2001/XMLSchema#string